Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Tran

Showing results (131-140 of 181) with videos related to

Pageof 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2019
Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver DiseaseEdward Gane, Fred Poordad, Neddie Zadeikis, et al.
Clinics and Research in Hepatology and Gastroenterology|April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic responseJessica Azzi, Céline Dorival, Carole Cagnot, et al.
The American Journal of Gastroenterology|March 18, 2006
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca studyPhilippe Halfon, Marc Bourliere, Romaric Deydier, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2023
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trialMax Seidensticker, Osman Öcal, Kerstin Schütte, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
A Non-canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging LiverSabira Mohammed, Chao Jiang, Travis Pennington, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2020
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosisArmand Abergel, Tarik Asselah, Arianne Mallat, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2025
CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of SteatohepatitisManon Bourinet, Elodie Vieira, Déborah Rousseau, et al.
ERJ Open Research|July 15, 2021
Vaping-induced metabolomic signatures in the circulation of mice are driven by device type, e-liquid, exposure duration and sexAlexander Moshensky, Mulong Du, John Shin, et al.
Journal of Hepatology|February 24, 2015
Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-respondersDonald Jensen, Kenneth E Sherman, Christophe Hézode, et al.
Biomedicines|February 25, 2023
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in HepatocytesAinara Cano, Mercedes Vazquez-Chantada, Javier Conde-Vancells, et al.
Pageof 19

Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2019
Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver DiseaseEdward Gane, Fred Poordad, Neddie Zadeikis, et al.
Clinics and Research in Hepatology and Gastroenterology|April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic responseJessica Azzi, Céline Dorival, Carole Cagnot, et al.
The American Journal of Gastroenterology|March 18, 2006
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca studyPhilippe Halfon, Marc Bourliere, Romaric Deydier, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2023
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trialMax Seidensticker, Osman Öcal, Kerstin Schütte, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
A Non-canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging LiverSabira Mohammed, Chao Jiang, Travis Pennington, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2020
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosisArmand Abergel, Tarik Asselah, Arianne Mallat, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2025
CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of SteatohepatitisManon Bourinet, Elodie Vieira, Déborah Rousseau, et al.
ERJ Open Research|July 15, 2021
Vaping-induced metabolomic signatures in the circulation of mice are driven by device type, e-liquid, exposure duration and sexAlexander Moshensky, Mulong Du, John Shin, et al.
Journal of Hepatology|February 24, 2015
Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-respondersDonald Jensen, Kenneth E Sherman, Christophe Hézode, et al.
Biomedicines|February 25, 2023
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in HepatocytesAinara Cano, Mercedes Vazquez-Chantada, Javier Conde-Vancells, et al.
Pageof 19